An expert in connective tissue disease–associated interstitial lung disease described best approaches for rheumatologists to ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...

Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...

Pneumonia is a lung infection that can be caused by a number of different organisms, including bacteria, viruses, and fungi. It happens when your immune system isn't able to prevent these organisms ...

MORTALITY is higher in those with ANCA-positive interstitial lung disease (ILD) compared to those with ANCA-negative ILD, ...

DelveInsight's "TEPMETKO Market Size, Forecast, and Market Insight Report" highlights the details around TEPMETKO, a kinase ...

The new chief medical officer of the Pulmonary Fibrosis Foundation speaks about patients in rural areas, research ...

True or false: Pulmonary function tests (PFTs) are sufficient for detecting ILD among patients with newly diagnosed SARDs.

The following is a summary of "Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients," published in the January 2025 issue of ...

SAN DIEGO, March 06, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology ...

Cefiderocol exhibited clinical utility among a cohort of immunocompromised adult inpatients with MDR infections.

This is because the scarring causes the tissues in the lungs to get thick and stiff and makes it hard to absorb oxygen into the bloodstream. Pulmonary fibrosis is an interstitial lung disease.